Open AccessSevere Pulmonary Involvement in Leptospirosis : Alternate Antibiotics and Systemic Steroids = المضاعفات الرئوية الشديدة لمرض البريميات : المضادات الحيوية و أدوية الكورتيزون بالتبادل
Author(s) -
B Jayakrishnan,
Fatma Ben Abid,
Abdullah Balkhair,
Juma K. Alkaabi,
Omar A Al-Rawas,
Jojy George,
Khalfan Al-Zeedy
Publication year - 2013
Publication title -
sultan qaboos university medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.258
H-Index - 27
eISSN - 2075-0528
pISSN - 2075-051X
DOI - 10.12816/0003241
Subject(s) - medicine , leptospirosis , meropenem , moxifloxacin , antibiotics , systemic antibiotics , intensive care medicine , pathology , antibiotic resistance , microbiology and biotechnology , biology
Pulmonary complications in leptospirosis, though common, are often unrecognized in a non-endemic area. We report here a patient with leptospirosis and severe pulmonary involvement who was treated with meropenem (1 g every 8 hours), moxifloxacin (400 mg once daily), and high doses of corticosteroids. Systemic steroids were continued for 3 months because of persistent pulmonary lesions.